SELLAS Life Sciences Group, Inc.

NasdaqCM:SLS Stock Report

Market Cap: US$154.4m

SELLAS Life Sciences Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SLS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders285,4950.314%
Institutions6,716,8567.39%
Hedge Funds7,579,0958.34%
General Public76,265,24683.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 57.3%.


Top Shareholders

Top 25 shareholders own 15.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.34%
Anson Group
7,579,095US$12.9m536%2.22%
3.13%
The Vanguard Group, Inc.
2,839,318US$4.8m23.8%no data
0.9%
Geode Capital Management, LLC
820,440US$1.4m11.9%no data
0.76%
Susquehanna International Group, LLP, Asset Management Arm
688,696US$1.2m0%no data
0.59%
BlackRock, Inc.
538,460US$915.4k21.2%no data
0.38%
Citadel Advisors LLC
349,505US$594.2k-28%no data
0.3%
State Street Global Advisors, Inc.
277,029US$470.9k21.7%no data
0.26%
Opus Capital Management, LLC
239,500US$407.1k0.42%0.05%
0.18%
Northern Trust Global Investments
164,390US$279.5k22%no data
0.12%
Angelos Stergiou
108,882US$185.1k4.81%no data
0.073%
Morgan Stanley, Investment Banking and Brokerage Investments
66,450US$113.0k321%no data
0.072%
LPL Financial Corporation, Asset Management Arm
65,744US$111.8k26.7%no data
0.071%
Atom Investors LP
64,216US$109.2k0%0.01%
0.069%
UBS Asset Management AG
62,231US$105.8k-51.3%no data
0.064%
Jane Street Group, LLC, Asset Management Arm
58,541US$99.5k376%no data
0.059%
Virtu Financial LLC, Asset Management Arm
53,861US$91.6k30.9%no data
0.056%
Mariner, LLC
51,200US$87.0k1.17%no data
0.055%
Dragan Cicic
50,328US$85.6k22.1%no data
0.053%
John Burns
48,603US$82.6k15.4%no data
0.053%
Two Sigma Investments, LP
48,287US$82.1k0%no data
0.038%
Renaissance Technologies LLC
34,892US$59.3k0%no data
0.03%
Jain Global LLC
27,400US$46.6k0%no data
0.025%
GSA Capital Partners LLP
22,727US$38.6k0%no data
0.023%
Tower Research Capital Europe Limited
20,889US$35.5k294%no data
0.023%
Quadrature Capital Limited
20,673US$35.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 23:40
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SELLAS Life Sciences Group, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Joseph PantginisH.C. Wainwright & Co.
Aydin HuseynovLadenburg Thalmann & Company